Stereotaxis (STXS) Short term Debt (2010 - 2026)

Stereotaxis (STXS) posted quarterly Short term Debt of $5.3 million for Q1 2026, up 7.6% quarter-over-quarter from $4.9 million in Q4 2025.

Stereotaxis (STXS) Short term Debt (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has reported Short term Debt for 10 consecutive years, with $5.3 million the latest figure, recorded in Q1 2026.

In Q1 2026, Short term Debt changed N/A year-over-year to $5.3 million; the TTM figure through Mar 2026 stood at $5.3 million (changed N/A YoY), while the FY2025 annual figure was $4.9 million, down 13.2% from the prior year.
Short term Debt rose to $5.3 million in Q1 2026 per STXS's latest filing, from $4.9 million in the prior quarter.
Across five years, Short term Debt topped out at $5.6 million in Q4 2024 and bottomed at $4.9 million in Q4 2025.
Historically, Short term Debt has averaged $5.3 million across 3 years, with a median of $5.4 million in 2025.
On a YoY basis, Short term Debt climbed as much as 13.2% in 2025 and fell as far as 13.2% in 2025.
Stereotaxis' Short term Debt stood at $5.6 million in 2024, then fell by 13.2% to $4.9 million in 2025, then gained by 7.6% to $5.3 million in 2026.
Business Quant data shows STXS's Short term Debt at $5.3 million in Q1 2026, $4.9 million in Q4 2025, and $5.6 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn
10	Stereotaxis	141.91 Mn	127.29 Mn	3.79 Mn

Download Data